Exelixis Inc 's ability to collect accounts receivable sequentially worsen to 7.8, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Exelixis Inc 's Accounts Receivable average collection period in the Apr 03 2026 quarter, has increased to 47 days, from 46 days, in the Jan 02 2026 quarter.

If we take a look into Healthcare sector 179 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1635, from overall ranking in the fourth quarter 2025 at 1865.

What is Receivable Turnover Ratio?
What is Exelixis Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EXEL Receivables Turnover Ratio	(Apr 03 2026) I. Quarter	(Jan 02 2026) IV. Quarter	(Oct 03 2025) III. Quarter	(Jul 04 2025) II. Quarter	(Apr 04 2025) I. Quarter
Y / Y Receivable Change	16.8 %	8.09 %	14.84 %	-26.28 %	17.07 %
Y / Y Revenue Change	9.97 %	5.63 %	10.79 %	-10.82 %	30.62 %
Receivable Turnover Ratio (TTM)	7.8	7.93	7.96	8.04	7.58
EXEL's Total Ranking	# 1635	# 1865	# 1687	# 1665	# 1806
Accounts Receivable average collection period days	47	46	46	45	48
Seq. Receivable Change	14.65 %	-7.36 %	5.94 %	3.81 %	6.1 %
Seq. Revenue Change	2.03 %	0.15 %	5.19 %	2.31 %	-2 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 21
Healthcare Sector	# 180
Overall Market	# 1635

Receivable Turnover Ratio Statistics
High	Average	Low
25.49	8.46	3.99
(Jun 29 2012)		(Sep 30 2016)

EXEL Company Profile • Back to EXEL Efficiency Comparisons • Compare EXEL Receivables Turnover Ratio to its Competitors

Financial Statements
Exelixis Inc 's Accounts Receivable	$ 329 Millions	Visit EXEL's Balance sheet
Exelixis Inc 's Sales TTM	$ 2,375 Millions	Visit EXEL's Income Statement
Sources of EXEL's Revenues		Visit EXEL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
EXEL's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
EXEL's Growth Rates	EXEL's Roa	EXEL's Inventory Turnover Ratio	EXEL's Dividend Comparisons
EXEL's Profitability Ratios	EXEL's Roi	EXEL's Asset Turnover Ratio	EXEL's Dividend Growth
EXEL's Valuation Ratios	EXEL's Roe	EXEL's Financial Strength Ratios	EXEL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Apr 03 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Apr 03 2026	Receivable at quarter ending Apr 03 2026
Longeveron Inc	19.07	$ 1.216 Millions	$ 0.064 Millions
Sonida Senior Living Inc	18.82	$ 411.850 Millions	$ 21.878 Millions
Voyager Therapeutics Inc	17.99	$ 36.494 Millions	$ 2.029 Millions
Nutriband Inc	16.79	$ 1.803 Millions	$ 0.107 Millions
Bioadaptives Inc	16.64	$ 0.024 Millions	$ 0.001 Millions
Premier Air Charter Holdings Inc	16.33	$ 33.205 Millions	$ 2.033 Millions
Bioage Labs Inc	15.90	$ 10.316 Millions	$ 0.649 Millions
Escalon Medical Corp	15.15	$ 11.445 Millions	$ 0.756 Millions
Nurix Therapeutics Inc	15.11	$ 71.779 Millions	$ 4.750 Millions
Lexicon Pharmaceuticals Inc	14.91	$ 69.643 Millions	$ 4.670 Millions
Qhslab Inc	14.80	$ 2.775 Millions	$ 0.188 Millions
Nexgel Inc	14.19	$ 10.382 Millions	$ 0.732 Millions
Sutro Biopharma Inc	14.04	$ 99.608 Millions	$ 7.095 Millions
Precipio inc	13.93	$ 25.831 Millions	$ 1.854 Millions
China Pharma Holdings Inc	13.86	$ 3.992 Millions	$ 0.288 Millions
Talkspace Inc	13.67	$ 239.269 Millions	$ 17.501 Millions
Marpai Inc	13.59	$ 17.125 Millions	$ 1.261 Millions
Amneal Pharmaceuticals Inc	13.56	$ 3,045.530 Millions	$ 224.634 Millions
Corcept Therapeutics Inc	13.20	$ 769.096 Millions	$ 58.264 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Xoma Royalty Corporation	13.05	$ 48.555 Millions	$ 3.720 Millions
Mannkind Corporation	13.00	$ 360.783 Millions	$ 27.757 Millions
Lifestance Health Group Inc	12.74	$ 1,494.791 Millions	$ 117.296 Millions
Chemed Corporation	12.73	$ 2,540.548 Millions	$ 199.626 Millions
Milestone Scientific Inc	12.69	$ 8.337 Millions	$ 0.657 Millions
Lftd Partners Inc	12.55	$ 36.955 Millions	$ 2.945 Millions
Clene Inc	12.47	$ 0.134 Millions	$ 0.011 Millions
Skinhealth Systems Inc	12.27	$ 295.223 Millions	$ 24.052 Millions
Cytokinetics Incorporated	12.16	$ 105.815 Millions	$ 8.702 Millions
Precision Biosciences Inc	11.94	$ 45.073 Millions	$ 3.776 Millions

Date modified: 2026-08-29T17:16:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.